AIVI0.256%
as of Jul 17
HLN
DefensiveHaleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.
Close · 3M
-2.14%
Held by 2 AI ETFs
PQNT0.250%
as of Jul 21
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals8
Win rate88% (7/8)
Avg buy return+5.29%
AIVI · Weight increase · 2d
Haleon plc (HLN), currently trading at $10.10, is positioned at 90% of its 52-week high after experiencing a 12.7% return over the last 30 days, despite remaining flat to negative over longer 90-day and 1-year periods. This recent upward momentum, contrasting with its prior 90-day and 1-year returns of -0.7% and -0.5% respectively, suggests a recent re-evaluation, which could be a factor for WisdomTree’s AIVI. AIVI’s AI selection, operating within its developed-international value-factor pool, likely detected HLN's current price and short-term trajectory as aligning with its proprietary value metrics, leading to the consecutive weight increases on July 16th and 17th. These adjustments, occurring within a fund that rebalances periodically rather than daily, indicate a determined AI assessment that found increased merit in HLN’s position within its portfolio of approximately 100 international developed-market value stocks.
weight 0.245% → 0.256% (+0.010 pp)·stock up 11.1% in the 30 days before
Jul 17·entry $10.10·now $10.04Fresh
-0.59%
since Jul 17
AIVI · Accumulation · 5d
Haleon plc currently trades at $9.70, a position 86% from its 52-week high of $11.27, following a 90-day decline of 6.1% and a one-year drop of 6.3%. This price trajectory, showing a significant retreat from its yearly peak before a recent 30-day gain of 9.7%, aligns with AIVI's methodology of AI selection within a developed-international value-factor pool. The AI's gradual accumulation of HLN shares, evidenced by its weight increasing from 0.2412% to 0.2504% over two weeks, indicates its algorithm likely identified the healthcare company as a compelling value opportunity after its prolonged downturn. This selective increase suggests the AI prioritizes stocks like HLN that have moved off their highs and potentially offer valuation appeal within the international value equity space.
weight 0.241% → 0.250% (+0.009 pp)·stock up 8.6% in the 30 days before
Jul 13·entry $9.86·now $10.04Fresh
+1.83%
since Jul 13
AIVI · Weight increase · 2d
The weight for HLN within AIVI shows a clear, gradual increase from 0.2422% to 0.2511% over approximately two weeks, marked by staggered accumulation and minor daily fluctuations around a distinct upward trend. This incremental positioning occurs as HLN trades at $9.71, a price point approximately 86% off its 52-week high, indicating a potentially attractive entry for a value-focused strategy. Given AIVI's international value-factor mandate and AI selection method, the algorithm likely identified HLN as an undervalued health care stock following its 90-day return of -10.7% and 1-year return of -6.8%. Such deliberate, periodic adjustments demonstrate the AI's systematic approach to building positions in stocks that meet its value criteria, particularly those significantly off their prior peaks.
weight 0.245% → 0.251% (+0.006 pp)·stock up 6.9% in the 30 days before
Jul 8·entry $9.75·now $10.04Drifting
+2.97%
since Jul 8
AIVI · Accumulation · 5d
Haleon plc (HLN) shows a consistent, measured accumulation within AIVI, with its weight steadily rising from 0.2233% to 0.2485% over eight tracking days through early July. This gradual increase by the WisdomTree AI-managed ETF aligns with HLN's current price of $9.82, which reflects a -11.4% 90-day return and a -5.7% 1-year return, placing it at 87% of its 52-week high. Such a pattern suggests AIVI's AI selection algorithm, operating within a developed-international value-factor pool, likely identified HLN as a compelling value opportunity after its recent price depreciation. The methodical accumulation, rather than a sharp single adjustment, is consistent with the ETF's strategy of periodic rebalances, systematically building exposure in an underserved international value market.
weight 0.223% → 0.248% (+0.025 pp)·stock up 12.9% in the 30 days before
Jul 2·entry $9.82·now $10.04Drifting
+2.24%
since Jul 2
AIVI · Weight increase · 3d
WisdomTree's AIVI, an ETF employing AI selection within a developed-international value-factor pool, has recently increased its weighting in Haleon plc. The AI's decisions, made during periodic rebalancing for its approximately 100-stock portfolio, seem to reflect a response to HLN's recent market performance. Following a -17.6% 90-day return, the AI initiated a series of consecutive weight increases from 0.2233% to 0.2422% between June 23rd and June 25th. This sustained buying activity suggests the AI identifies HLN, trading at $9.24 and 82% of its 52-week high, as a compelling value opportunity within its international value universe.
weight 0.223% → 0.242% (+0.019 pp)·stock up 0.3% in the 30 days before
Jun 25·entry $9.27·now $10.04Drifting
+8.31%
since Jun 25
AIVI · Weight increase · 2d
AIVI's AI selection method within its developed-international value-factor pool likely identified Haleon plc as a compelling opportunity for increased allocation. The ETF, which selects from approximately 100 international developed-market value stocks, appears to have increased its weighting in HLN after a period of price decline. This adjustment occurred as HLN experienced a 90-day return of -17.6%, positioning the stock at a lower valuation that aligns with the fund's international value style. The AI's periodic rebalancing decision to increase its stake to 0.2365% suggests a specific read on HLN at its current $9.23 price point, notably 82% of its 52-week high.
weight 0.223% → 0.236% (+0.013 pp)·stock down 0.6% in the 30 days before
Jun 24·entry $9.23·now $10.04Drifting
+8.78%
since Jun 24
AIVI · Weight decrease · 4d
The weight for Haleon plc (HLN) within AIVI exhibited a cadence of subtle, consecutive decreases from 0.2314% on June 12th to 0.2260% by June 16th. This type of gradual adjustment, rather than a sharp shift, aligns with WisdomTree’s AIVI, which utilizes an AI overlay for periodic rebalancing within its international developed-market value-factor pool. Despite HLN trading near its 52-week low at $8.87 and experiencing significant price declines, AIVI's AI selection method suggests a re-evaluation of the company’s value proposition. The incremental reductions indicate the AI likely identifies weakening value characteristics or a lack of perceived upside for HLN within its value mandate, prompting a measured decrease in allocation across the portfolio of approximately 100 international value stocks.
weight 0.236% → 0.226% (-0.010 pp)·stock up 1.5% in the 30 days before
Jun 16·entry $9.09·now $10.04
+10.45%
since Jun 16
AIVI · Weight decrease · 3d
HLN's 90-day return of -16.5% and 1-year return of -17.9% positions the stock, currently at $9.07 and 80% of its 52-week high, as a deeper value consideration for AIVI. As an ETF employing AI selection within a developed-international value-factor pool, AIVI registered a consecutive weight decrease for HLN from 0.2326% on 2026-06-11 to 0.2280% by 2026-06-15. This specific reduction in AIVI’s allocation to the health care company, occurring while HLN’s price continued to reflect long-term underperformance, suggests the AI overlay periodically reassessed its intrinsic value. The AI's decision to lessen HLN’s weighting despite its lower absolute price indicates a reevaluation of the stock’s suitability within the fund's international value mandate.
weight 0.236% → 0.228% (-0.008 pp)·stock up 1.8% in the 30 days before
Jun 15·entry $9.07·now $10.04
+10.69%
since Jun 15
AIVI · Weight decrease · 2d
HLN currently trades at $9.13, hovering near its 52-week low of $8.70, having logged a -20.0% return over the past year and a -15.3% decline over 90 days. Against this backdrop, AIVI, an AI-managed ETF focused on developed-international value stocks, exhibited a pattern of consecutive weight decreases in HLN. This specific action suggests the AI’s methodology, which selects from an approximately 100-stock international developed-market portfolio, is not identifying sufficient underlying value or a positive reversal for HLN at its current price levels, despite its proximity to the bottom of its 52-week range. The fund’s periodic rebalancing schedule allows the AI to adjust exposure to companies like HLN, a healthcare stock, reducing its allocation as the stock’s perceived value characteristics evolve or its price continues a prolonged decline.
weight 0.236% → 0.231% (-0.005 pp)·stock up 1.2% in the 30 days before
Jun 12·entry $9.13·now $10.04
+9.97%
since Jun 12
AIVI · Weight increase · 2d
weight 0.226% → 0.238% (+0.012 pp)·stock down 1.2% in the 30 days before
Jun 5·entry $9.12·now $10.04Chased
+10.09%
since Jun 5
AIVI · Weight decrease · 2d
HLN's recent performance metrics, including a -21.1% 1-year return and its current $8.70 price at the 52-week low, position it at 76% of its 52-week high. These figures might typically attract attention for an international value ETF, given AIVI's mandate to select within a developed-international value-factor pool. Despite these deep value indicators, the AI overlay in AIVI initiated consecutive weight decreases for HLN on June 1st and 2nd, reducing its allocation from 0.2293% to 0.2257%. This action, particularly with Haleon plc now at its absolute 52-week floor, suggests the fund's AI algorithm identified an erosion of fundamental value or a persistent negative trend not aligning with its selection criteria, even at the $8.70 price level. The AI's periodic rebalance appears to be reallocating away from Haleon plc, indicating a specific re-evaluation of its long-term value potential within the international developed-market value universe.
weight 0.237% → 0.226% (-0.011 pp)·stock down 7.2% in the 30 days before
Jun 2·entry $8.70·now $10.04
+15.40%
since Jun 2
AIVI · Weight decrease · 2d
The AI likely decreased HLN's weight consecutively due to consistently negative quantitative signals, such as deteriorating financial metrics, underperformance relative to peers, or a shift in market sentiment detected through news analysis, indicating a worsening risk-reward profile for the stock. For a retail investor, this systematic reduction by an AI ETF serves as a strong signal to re-evaluate their own investment thesis for HLN, prompting deeper research into the company's fundamentals and recent market developments before making personal portfolio decisions.
weight 0.240% → 0.234% (-0.006 pp)·stock down 7.8% in the 30 days before
May 14·entry $8.91·now $10.04
+12.68%
since May 14
AIVI · Weight decrease · 2d
The AI ETF's continuous reduction in HLN's weight likely stems from its algorithms detecting weakening fundamental metrics, negative price momentum, or increasing risk factors associated with the company or the healthcare sector. This systematic divestment suggests the AI has identified better opportunities elsewhere or is actively de-risking its portfolio away from HLN. For retail investors, this pattern serves as a strong signal to re-evaluate their own holdings in HLN, prompting a deeper dive into recent company news, earnings reports, and sector trends. It underscores the importance of independent research and active portfolio monitoring when advanced algorithms are consistently reducing exposure.
weight 0.240% → 0.234% (-0.005 pp)·stock down 8.7% in the 30 days before
May 11·entry $8.98·now $10.04
+11.80%
since May 11
AIVI · Weight decrease · 2d
The AI ETF is systematically reducing its weight in HLN, likely due to its algorithms detecting deteriorating fundamental or technical signals, or increased risk for the healthcare stock. This consistent rebalancing indicates the AI model has identified negative momentum or a less favorable outlook. For retail investors, this serves as a cautionary signal to perform thorough due diligence on HLN, investigating potential underlying issues before making investment decisions.
weight 0.251% → 0.241% (-0.010 pp)·stock down 6.6% in the 30 days before
May 6·entry $9.23·now $10.04
+8.78%
since May 6
AIVI · Weight increase · 2d
The AI-managed ETF likely initiated consecutive weight increases in HLN as its algorithms detected improving fundamental metrics or positive price momentum, potentially positioning the healthcare stock as an attractive defensive holding. For a retail investor, this pattern suggests the AI has identified a positive outlook for HLN, warranting further personal research into the company's recent performance and market catalysts before considering it for their own portfolio.
weight 0.247% → 0.251% (+0.004 pp)·stock down 6.9% in the 30 days before
May 4·entry $9.24·now $10.04Drifting
+8.66%
since May 4
AIVI · Weight decrease · 2d
The AI ETF likely detected deteriorating fundamental metrics, weakening technical indicators, or a negative shift in the healthcare sector's outlook for HLN, prompting a continuous reduction in exposure to mitigate risk or optimize portfolio allocation. For a retail investor, this pattern serves as a strong signal to conduct personal due diligence on HLN's current fundamentals and technicals before making any investment decisions.
weight 0.255% → 0.247% (-0.008 pp)·stock down 7.7% in the 30 days before
Apr 30·entry $9.24·now $10.04
+8.66%
since Apr 30
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.